Skip to content

A Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy

Management of Chronic Lower Back Pain: A Randomized Controlled Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy Utilizing a Point of Care Methodology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03049644
Enrollment
15
Registered
2017-02-10
Start date
2017-02-01
Completion date
2018-12-30
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lower Back Pain

Keywords

chronic lower back pain, Manual Therapy, Mechanical Diagnosis and Treatment

Brief summary

Mechanical diagnosis and treatment (MDT) and Manual Therapy (MT) have both demonstrated efficacy in the management of CLBP. The use of a Point of Care (POC) design in this study will allow for comparison of these two treatment modalities in a clinical setting. The purpose of this study is to demonstrate the feasibility of recruiting, enrolling and collecting outcome data on CLBP patients utilizing the POC methodology.

Detailed description

20 new patients entering the chiropractic clinic who meet inclusion criteria including demonstrating a directional preference upon physical examination during their initial evaluation will be recruited. Patients will be queried as to interest and those interested will be consented. Patients will then be randomized utilizing a computer generated randomization chart to receive either MDT or MT delivered in a pragmatic manner. Outcomes will include: Pain (PEG), Quality of Life (PROMIS Global Health Survey (GHS)), psychosocial questions and Self Efficacy (2 Question). Outcomes will be collected at baseline, 4 weeks and 8 weeks post baseline.

Interventions

PROCEDUREMechanical Diagnosis and Therapy

Identification of directional preference.

PROCEDUREManual Therapy

Mechanically based treatment based on taking joint to end range and thrusting or soft tissue manipulation.

Sponsors

Canandaigua VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Chronic Lower back pain (CLBP) (\>12 weeks) * Veteran * At least 18 years of age * Directional preference on physical examination

Exclusion criteria

* Non Veteran * \>89 years of age * Non Mechanical Cause of LBP * Unable to identify directional preference on physical examination * Contraindications to manual therapy (cauda equina syndrome, spinal neoplasia or metastatic disease, destructive joint pathology such as rheumatoid arthritis, bowel/bladder dysfunction (associated with the back pain), peripheral neuropathy or progressive lumbosacral radiculopathy, progressive myelopathy or neurogenic claudication or any absolute contraindications to MT such as acute fracture of the lumbar spine) * Open Worker's compensation case

Design outcomes

Primary

MeasureTime frameDescription
PROMIS Global Health Scale (GHS)baseline, 4 week and 8 week (assessing change from baseline to 4 weeks and 8 weeks)Change in Quality of Life Measure

Secondary

MeasureTime frameDescription
PEG (Pain/enjoyment of life/general activity)baseline, 4 week and 8 week (assessing change from baseline to 4 weeks and 8 weeks)Change in Pain
Fear Avoidancebaseline, 4 week and 8 week (assessing change from baseline to 4 weeks and 8 weeks)It's not really safe for a person with my back problem to be physically active (1-5 scale)
Catastrophizingbaseline, 4 week and 8 week (assessing change from baseline to 4 weeks and 8 weeks)I feel that my back pain is terrible and it's never going to get any better (1-5 scale)
Behavioral Disengagementbaseline, 4 week and 8 week (assessing change from baseline to 4 weeks and 8 weeks)Due to my chronic back pain, I no longer engage in activities that are enjoyable and pleasant (1-5 scale\_

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026